Page last updated: 2024-08-21

aminoimidazole carboxamide and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

aminoimidazole carboxamide has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, K; Croft, KD; Keaney, JF; Li, C; Ward, NC	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and 20-hydroxy-5,8,11,14-eicosatetraenoic acid

Article	Year
Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction. Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:5 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aorta; Cells, Cultured; Cytoprotection; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Activators; Humans; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribonucleotides; Time Factors; Vascular Diseases; Vasoconstrictor Agents	2011

Article

Year

Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction.

Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:5

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aorta; Cells, Cultured; Cytoprotection; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Activators; Humans; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribonucleotides; Time Factors; Vascular Diseases; Vasoconstrictor Agents

2011